Although we observed an overrepresentation of CAIX positive immunoreactivity in prostate carcinoma compared to BPH, the nonsynonymous SNP in CA9 + 201 were unable to explain variations in the levels of CAIX protein expression in the prostatic tissue. The gene discussed is CA9; the disease is prostate carcinoma.